RJFSA
CTIC

Raymond James Financial Services Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,571
Closed -$102K – 3451
2022
Q3 		$102K Buy
+17,571
New +$110K ﹤0.01% 2992
2022
Q2 		– Sell
-15,571
Closed -$73K – 3500
2022
Q1 		$73K Buy
+15,571
New +$46.4K ﹤0.01% 3149
2021
Q4 		– Sell
-72,871
Closed -$215K – 3515
2021
Q3 		$215K Buy
+72,871
New +$198K ﹤0.01% 2932

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return